Catheter-Directed Thrombolysis for Deep Vein Thrombosis: Serving at Break Point

Venous thromboembolism (VTE), inclusive of both deep vein thrombosis (DVT) and pulmonary embolism, is a common, morbid, and sometimes deadly condition. It is estimated that more than 1 million Americans and more than 700,000 Europeans experience a VTE event annually.[1] Lifetime estimated risk of VTE in the United States is 8.1%, notably higher in black persons. Other important risk factors for developing VTE include obesity,[2] postsurgical populations,[3] recently hospitalized, cancer,[4] and those with sleep apnea.[5] Recent focus has included the associations of VTE to pregnancy and family history in women of childbearing age[6] [7] as well as those with assisted reproductive technology.[8] When patients experience a DVT, it negatively impacts their quality of life and limits their ability to participate as a productive member of society.[9]